Biologics Market Research Report by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines), by Application (Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases) - Global

Biologics Market Research Report by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines), by Application (Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases) - Global Forecast to 2025 - Cumulative Impact of COVID-19

The Global Biologics Market is expected to grow from USD 246,272.01 Million/EUR 215,935.98 Million in 2020 to USD 304,866.47 Million/EUR 267,312.71 by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.36%.

Market Segmentation & Coverage:

This research report categorizes the Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Biologics Market studied across Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies, Recombinant Hormones/Proteins, and Vaccines.

Based on Application, the Biologics Market studied across Autoimmune Diseases, Cancer, Infectious Diseases, and Rare Diseases.

Based on Geography, the Biologics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Market including AbbVie Inc., Amgen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novo Nordisk A/S, Pfizer Inc., and Sanofi SA.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biologics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Market?
4. What is the competitive strategic window for opportunities in the Global Biologics Market?
5. What are the technology trends and regulatory frameworks in the Global Biologics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Biologics Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
4.3. Geographic Growth Opportunities
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Attractive investment in the market from players
5.1.1.2. Rising prevalence of chronic diseases
5.1.1.3. Patent loss of leading biologic drugs
5.1.1.4. Availability of advanced diagnostics and rising government initiatives in healthcare
5.1.2. Restraints
5.1.2.1. Stringent regulatory process coupled with high capital investment
5.1.3. Opportunities
5.1.3.1. Higher acceptability for innovative therapies
5.1.3.2. Technological advancements in research and development across the globe
5.1.4. Challenges
5.1.4.1. Tightly controlled atmospheric conditions and maintained production process
5.1.4.2. Cost associated with access of biologics
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Global Biologics Market, By Product
6.1. Introduction
6.2. Cellular Based Biologics
6.3. Gene Based Biologics
6.4. Monoclonal Antibodies
6.5. Recombinant Hormones/Proteins
6.6. Vaccines
7. Global Biologics Market, By Application
7.1. Introduction
7.2. Autoimmune Diseases
7.3. Cancer
7.4. Infectious Diseases
7.5. Rare Diseases
8. Americas Biologics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biologics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. Europe, Middle East & Africa Biologics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AbbVie Inc.
12.2. Amgen, Inc.
12.3. Eli Lilly and Company
12.4. F. Hoffmann-La Roche AG
12.5. GlaxoSmithKline PLC
12.6. Johnson & Johnson
12.7. Merck & Co.
12.8. Novo Nordisk A/S
12.9. Pfizer Inc.
12.10. Sanofi SA
13. Appendix
13.1. Discussion Guide

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook